How to Treat the Root Cause of Psoriasis: The Gut Microbiome
What if psoriasis doesn’t start in your skin — but in your gut?
What this episode covers
- This episode explores the idea that gut health and identifiable triggers may contribute to psoriasis in some patients, alongside the well-established immune and genetic factors that mainstream dermatology focuses on.
- The gut-skin axis is a real and growing research area; the specific clinical translations discussed here (comprehensive stool testing, mold-toxin testing, structured elimination diets) outpace current dermatology guidance.
- What survives is concrete: psoriasis is increasingly understood as a systemic inflammatory condition with cardiovascular and metabolic implications, so reducing inflammatory triggers where they can be identified is reasonable alongside (not instead of) standard dermatology care.
Why it matters
Psoriasis is increasingly understood as a systemic inflammatory condition that can also affect the heart, joints, and mood — not only the skin. For some patients, the inflammation visible on the skin reflects broader processes that topical-only treatment may not fully address. Standard dermatology care remains the evidence base for active disease; food, gut, and lifestyle considerations may complement that care for patients whose symptoms persist or who want to address the broader inflammatory picture alongside conventional treatment.
What stands out
- Some reports suggest that cutting gluten helps about half of psoriasis patients while the other half see no change, so the response varies widely from person to person (large patient survey cited in episode)
- Clinical observations show that small drop-shaped (guttate) psoriasis flares often follow a strep throat infection by 1 to 3 weeks, yet routine dermatology care rarely tests for it specifically (clinical observation + case series)
- Biologic drugs can be highly effective for psoriasis but they treat inflammation after it develops; much less research has focused on identifying individual triggers before disease becomes established in a given patient (treatment-research framing)
Best-supported action
The single highest-leverage move from this episode, anchored in the strongest evidence the speaker presents.
Track your skin (a simple 0-10 weekly score), diet, stress, sleep, and other potential triggers for four to six weeks before starting any elimination protocol — this baseline observation makes any subsequent dietary or lifestyle change much more interpretable, and reflects the underlying point that psoriasis triggers vary substantially person to person.
Where to start
Small low-friction starters covering the main moves from this episode.
- Pay attention to how flares line up with stress, illness, or food changes
- Notice if you live or work in a damp or musty environment
- Ask your doctor whether your psoriasis care includes cardiovascular and mental health checks
Other supported actions
Further actions discussed in this episode, ordered from strongest to weakest evidence. This is one expert's view, the full topic compares and ranks across experts.
- Track your psoriasis (a simple 0-10 weekly score), diet, stress, sleep, and recent infections for four to six weeks before changing anything — this baseline observation makes any subsequent dietary or testing decision much more interpretable, and is the foundational move regardless of which trigger framework you pursue.Strong evidence
- If your flares repeatedly follow throat infections or you have a history of guttate psoriasis presentations, discuss strep antibody testing (ASO and anti-DNase B) with your dermatologist or primary-care doctor. This is the most evidence-supported trigger-identification step in psoriasis care.Moderate evidence
- If symptoms persist after the observation phase and you want to explore dietary triggers, consider a structured elimination diet (gluten, dairy, or added sugar one at a time, not all at once) with photo and symptom tracking. Reserve comprehensive stool testing or mold-toxin testing for selected patients after discussion with a clinician who can interpret them in context — these tests are not currently part of standard dermatology workup and may not change management.Limited evidence
Full context, impact ratings, and timing — available in related topics
Questions to take to your doctor
- Given my history of psoriasis flares, could there be identifiable triggers (recent infections, stress periods, dietary changes, medications) worth investigating in my case before changing my treatment plan?
- If my flares follow throat infections, would you check for hidden streptococcal involvement with ASO and anti-DNase B antibody testing, particularly if I have guttate-presentation psoriasis?
- Given psoriasis is now understood as a systemic inflammatory condition, what cardiovascular and metabolic screening would you recommend for me alongside my dermatology care?
- If I want to try a structured elimination diet to look for personal food triggers, what would you consider a reasonable trial length and what would you want to track to know if it is helping?
- If my current dermatology treatment is working but I want to explore additional layers (gut, stress, lifestyle), how would you frame the role of those layers relative to my standard care?
Full doctor prep with ranked questions available in the full topic page
Context
The expert emphasizes translating research into actionable steps, focusing on what the evidence actually supports versus common assumptions.
This episode does not prove that psoriasis begins in the gut for most people, that stool testing identifies the cause of psoriasis, or that elimination diets replace standard dermatology treatment. The gut-skin axis is a real and growing research area, but specific clinical translations (which patients benefit from which protocol, at which point in their disease) remain under investigation. Some patients may identify useful triggers; others may not, and absence of an identifiable trigger is itself common and not a sign that something has been missed. The clinical reasoning is based primarily on one clinician's case observations rather than large randomized trials. Standard dermatology care — including topical therapy, phototherapy, and biologics where appropriate — remains the evidence base for active disease; trigger investigation and lifestyle work can complement that care for many patients but are not currently established as a replacement for it.
Where people go wrong
- Treating psoriasis as only a skin problem and ignoring the inflammation inside the bodyHeart and metabolic risks may keep climbing while only the skin surface gets managed
- Assuming medication alone is the whole answer without discussing potential triggers or broader inflammatory health factors with your clinician.Standard dermatology care (including biologics where appropriate) remains the evidence base for active psoriasis. Trigger identification and lifestyle work can complement that care for many patients — particularly given psoriasis's systemic inflammatory and cardiovascular dimensions — but the layering depends on individual circumstances and is best discussed with your dermatologist rather than pursued in parallel without communication.
What to expect over time
- Weeks 1-4If you begin tracking symptoms — or make one carefully chosen lifestyle change — early patterns may start to emerge. Some people notice reduced itching or fewer flares; others see little change. The observation phase is valuable regardless of the outcome because it creates a baseline for future decisions and makes any subsequent change much more interpretable.
- Months 2-4If a meaningful personal trigger has been identified (recent infection, dietary pattern, environmental exposure) and is being addressed, symptoms may improve gradually over this window. Many people continue to require standard dermatology treatment despite lifestyle and trigger work — both layers can run in parallel.
- Months 6-12Psoriasis often requires long-term management rather than a single solution. The most durable approach combines treatments that control inflammation (topical therapy, phototherapy, biologics where appropriate) with a better understanding of the personal factors that influence individual disease activity. Continued conversation with your dermatologist about what is and is not helping remains the steady framework.